SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-003413
Filing Date
2020-03-05
Accepted
2020-03-05 08:11:56
Documents
104
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2149103
2 ex4-7.htm EX-4.7 39896
3 ex10-42.htm EX-10.42 24259
4 ex10-43.htm EX-10.43 52733
5 ex23-1.htm EX-23.1 4411
6 ex31-1.htm EX-31.1 18536
7 ex31-2.htm EX-31.2 18641
8 ex32-1.htm EX-32.1 6063
9 ex32-2.htm EX-32.2 6335
10 logo_001.jpg GRAPHIC 40721
  Complete submission text file 0001493152-20-003413.txt   7264259

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE vbiv-20191231.xml EX-101.INS 1032729
12 XBRL SCHEMA FILE vbiv-20191231.xsd EX-101.SCH 85838
13 XBRL CALCULATION FILE vbiv-20191231_cal.xml EX-101.CAL 84765
14 XBRL DEFINITION FILE vbiv-20191231_def.xml EX-101.DEF 307518
15 XBRL LABEL FILE vbiv-20191231_lab.xml EX-101.LAB 524835
16 XBRL PRESENTATION FILE vbiv-20191231_pre.xml EX-101.PRE 419645
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37769 | Film No.: 20689673
SIC: 2834 Pharmaceutical Preparations